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Abstract 
The susceptibilities of 106 strains of Aeromonas salmonicida to trimethoprim/sulfamethoxazole (SFT) were determined in two 
laboratories using the Clinical and Laboratory Standards Institute's M42-A disc diffusion protocols. The data generated by the use 
of discs containing 25 μg SFT (SFT25) allowed the strains to be placed into two groups. Strains in one group (17 strains) generated 
no inhibition zones and the zones obtained from the other 89 strains were distributed over a wide range but showed no natural 
division into separate sub-classes. A further investigation performed by one of the participating laboratories, of the susceptibility of 
91 of these 106 strains used discs containing 100 μg sulfmethoxazole (SFM100) and 5 μg trimethoprim (TMP5). Application of 
normalised resistance interpretation to these data allowed the estimation of epidemiological cut-off values for WT strains of 
≥ 9 mm for SFM100 and ≥ 21 mm for TMP5. This investigation demonstrated the presence of three distinct phenotypic classes, one 
containing strains manifesting wild type susceptibility to both agents, another containing strains manifesting non-wild type 
susceptibility to both and a third containing strains manifesting wild type susceptibility with respect to TMP but non-wild type with 
respect to SFM. Analysis demonstrated the inability of SFT25 discs to generate data that allowed the separate identification of 
strains that were fully susceptible to both TMP and SFM from those that were fully susceptible to TMP but were not fully 
susceptible to SFM. 
It is recommended that, in investigation of the susceptibility to potentiated sulphonamides of isolates from diseased fish, 
separate discs, containing the individual components of the mixture, should be employed. 
1. Introduction
There is a long history of the use of potentiated 
sulphonamide agents in the control of bacterial 
diseases of fish (Aoki et al., 1972). In the US and 
Canada the most commonly used products are those 
containing a mixture of ormetoprim and sulfadi- 
methoxine in a ratio of 1:19 (SFO). In Europe the 
preferred mixture has been trimethoprim and sulfa- 
methoxazole in the same ratio (SFT). Currently there 
are Marketing Authorisations for the use in aquaculture 
of 6 products containing trimethoprim/ sulfmethoxa-
zole in nine European countries 
2. Materials and methods
2006). 
(Guichard and Licek, 
2.1. Bacteria 
In the early 1970s Aoki et al. (1972) published on 
the plasmid location of genes involved in resistance to 
sulphonamides and plasmids encoding resistance to 
sulphonamides and to both sulphonamides and tri- 
methoprim have been detected in isolates made in 
Scotland and Ireland (Hedges et al., 1985; Inglis et al., 
1993). The very significant advances in our under- 
standing of the genetics of resistance have recently 
been documented by Sørum (2006). However, despite 
the long period during which these mixtures have been 
in use and our extensive knowledge of the molecular 
biology of the genetic mechanisms encoding resistance 
to them, there are still no standard validated break- 
points for assessing the clinical significance of in-vitro 
measures of susceptibility to SFT and SFO of isolates 
made from fish disease outbreaks. 
In a recent survey (Smith, 2006, 2007) of current 
practice, 29 of 31 responding laboratories reported 
using disc diffusion methods to determine the suscep- 
tibility of clinical isolates. Twenty-two (75%) of the 
laboratories reported the breakpoint values they 
employed to provide a clinical interpretation of 
inhibition zones generated by discs containing SFT. 
There was, however, considerable variation in the 
breakpoint values employed and those being used to 
define resistance by the 18 laboratories using 25 μg 
discs ranged from 8 mm to 23 mm. 
Standard methods for performing in-vitro disc 
diffusion susceptibility tests (M42-A) (CLSI, 2006a) 
have recently been issued by the Clinical Laboratory 
and Standards Institute (CLSI). This CLSI protocols is 
functionally equivalent to that previously published by 
Alderman and Smith (2001) but is associated with 
acceptable ranges for control strains. Miller and 
Reimschuessel (2006) have recently used the MIC and 
disc diffusion data generated by the application of the 
CLSI protocols (2006a,b) to 217 strains of Aeromonas 
salmonicida to estimate appropriate epidemiological 
cut-off values (EUCAST, 2000; Kahlmeter et al., 2003; 
CLSI, 2002) for SFO. 
In this work the M42-A protocols (CLSI, 2006a) 
were used to provide data on the susceptibility of 106 
strains of A. salmonicida to SFT. Given the pre- 
dominance of disc diffusion methods in laboratories 
dealing with clinical isolates (Smith, 2006, 2007), it 
was decided to confine the study to data generated 
by this method and to use the data from two indepen- 
dent laboratories to provide the necessary internal 
controls. 
2.1.1. Inter-laboratory studies with 25 μg trimethoprim/ 
sulfmethoxazole  discs 
One hundred and six strains of A. salmonicida were used in 
this work. All strains had been isolated from diseased fish, 
were brown pigmented and reacted with antiserum (BioNor 
MONO AQUA). These strains were received from Scotland 
(33 strains), Norway (30 strains), Denmark (17 strains), France 
(15 strains) and Ireland (11 strains). The control strain A. 
salmonicida NCIMB 1102 (equivalent to ACTC 33658) was 
obtained from the National Collection of Industrial and Marine 
Bacteria (UK). 
2.1.2. Studies in Laboratory 2 with 100 μg sulfmethoxazole 
discs and 5 μg trimethoprim discs 
Ninety-one of the 106 strains of A. salmonicida were used 
in this portion of the work. This strain set included 33 from 
Scotland, 27 from Norway, 14 from Denmark, 14 from France 
and 3 from Ireland. 
2.2. Media 
Bacteria were routinely cultured using a Mueller Hinton 
Agar or Mueller Hinton Broth purchased from Mast Group 
(Bootle, UK). Incubations were performed at 22±2 °C for 44 
– 48 h.
2.3. Discs 
Discs containing 25 μg trimethoprim/sulfmethoxazole 
(1:19)(SFT25), 100 μg sulfmethoxazole (SFM100) and 5 μg 
trimeth-oprim (TMP5) were obtained from Mast Group 
(Bootle, UK). 
2.4. Diffusion assay 
All disc diffusion assays were performed according to the 
protocols specified in M42-A (CLSI, 2006a). Suspensions 
were made in saline and incubations were at 22 ± 2 °C and 
zones were read after 44 – 48 h. A. salmonicida NCIMB 1102 
was used as the control strain. 
2.5. Statistical analysis 
Normalised resistance interpretation (NRI) was performed 
according to the method of Joneberg et al. (2003), Kronvall 
(2003) and Kronvall et al. (2003). Peak values were 
established using 5 point rolling means and the mean and 
standard deviation of the real distribution of fully susceptible 
(wild type) strains were calculated using a plot of probit values 
against zone size. In each case 6 probit values were plotted and 
these included the first value N5 and the next five values lower 
than this. Epidemiological cut-off values were set at two and 
a half standard deviations below the mean (Smith et al., 
in press). 
Fig. 1. Scatter-plot of the zone sizes recorded by the two laboratories using 25 μg trimethoprim/sulfamethoxazole (1:19) discs against all 106 strains 
of A. salmonicida. The vertical line indicates the cut-off value estimated by NRI analysis. 
All other statistical analyses were performed using InStat 
3.0 (GraphPad Inc). 
3. Results
3.1. Studies with SFT25 discs 
During these experiments the zone sizes for SFT25 discs 
against the control strain NCIMB 1102 were determined nine 
times by each laboratory and all determinations lay within the 
acceptable range (24 – 39 mm) specified by M42-A (CLSI, 
2006a) for tests performed under the conditions used in this 
work. The mean of the determinations by Laboratory 1 and 2 
were 26 ± 1.7 mm and 28 ± 0.8 mm respectively. 
With respect to the zone sizes they obtained for the 106 
strains tested both laboratories obtained similar distributions 
(Fig. 1) and no gross discrepancies were observed. It should be 
noted that the individual points in Fig. 1 might represent more 
Fig. 2. Inhibition zone diameters recorded by Laboratory 1 using 25 μg trimethoprim/sulfamethoxazole (1:19) discs against all 106 strains of 
A. salmonicida. Zones generated by Scottish strains are shown as solid bars. Zones for isolates from other countries are shown as striped bars. 
Table 1 
Zone size data recorded using 25 μg trimethoprim/sulfamethoxazole 
(1:19) discs 
test indicated that, in none of the national strain sets, were the 
frequencies of SFTNWT strains significantly different from that 
observed in the 106-strain set. 
All countries 




(n = 26) 3.1.2. Analysis of strains yielding zones N 7 mm with SFT25 
 (n = 63)  
LAB 1     LAB 2     LAB 1     LAB 2     LAB 1     LAB 2 
discs 
Table 1 presents the statistical parameters of the SFT25 zone 
Mean 28.2 28.0 30.7 29.7 23.0 24.3 size distributions obtained by the two laboratories for the 
SD 5.9 4.7 5.1 3.8 5.1 4.9 strains that generated zone sizes N 7 mm. When the zones from 
% CV 21 17 17 13 22 20 all 89 strains were considered as one set (the ‘All countries’ 
Median 29 28 31 30 22.5 23 columns in Table 1), the central tendency of the data obtained 
Min 14 16 19 21 14 16 by Laboratory 1 & 2 were remarkably similar (mean 28.2 mm 
Max 41 38 45 39 32 36 and 28.0 mm respectively). However these laboratories 
Statistical parameters of the data obtained from the 89 strains of 
A. salmonicida that gave zones N 7 mm, analysed by country of isolation. 
than one strain. Visual examination of the SFT25 data from the 
two laboratories (Figs. 2 and 5) suggested that the zone sizes 
fell into two clusters. Both laboratories recorded zones ≤ 7 mm 
for the same 17 strains and the zone sizes they recorded for the 
other 89 strains fell into a diffuse grouping that could not, on 
visual examination, be divided into discrete sub-groups. 
3.1.1. Frequency of strains with zones ≤ 7 mm with SFT25 
discs 
With respect to SFT25 discs, zones of inhibition of ≤ 7 mm 
were recorded by both laboratories for the same 17 strains and 
these could, therefore, be classified as non-wild type (NWT) 
with respect to SFT (SFTNWT). Application of Fisher's exact 
recorded high (21% and 17% respectively) coefficients of 
variation for these data. Despite these high degrees of variance, 
a visual examination of the distribution of the data for these 
strains (Figs. 2 and 5) provided no grounds for proposing the 
existence of discrete sub-groups within the 89 strains. There 
were, however, two lines of evidence that suggested that such 
sub-groups were in fact present. 
The first line of evidence derived from NRI analysis. Using 
this method to estimate the cut-off values for the wild type 
(WT) group resulted in values of ≥ 20 mm for Laboratory 1 
and ≥ 19 mm for Laboratory 2. However, for Laboratory 1, 
seven strains (8%) gave zones that were N 7 mm but b 20 mm. 
For Laboratory 2, three strains (3%) gave zones N 7 mm but 
b 19 mm. Setting the cut-off value for WT strains at the NRI 
mean minus two and a half standard deviations has the result 
that this lower limit should encompass N 99% of all sensitive 
strains. Thus, the frequency with which both laboratories 
Fig. 3. Inhibition zone diameters recorded by Laboratory 2 using 5 μg trimethoprim discs against 91 strains of A. salmonicida. 
Fig. 4. Inhibition zone diameters recorded by Laboratory 2 using 100 μg sulfamethoxazole discs against 91 strains of A. salmonicida. 
recorded SFT25 zones below their cut-off value for WT strains 
but greater than 7 mm, must be taken as evidence that a sub- 
population manifesting reduced susceptibility was present in 
the 89 strain set. 
The second line of evidence emerged when the 89 strain set 
data were analysed on the basis of the country of origin of the 
strains. Within the 89 strains that gave SFT25 zones N 7 mm, 
twenty-six originated from Scotland. Table 1 presents the 
Fig. 5. Inhibition zone diameters recorded by Laboratory 2 using 25 μg trimethoprim/sulfamethoxazole (1:19) discs against 91 strains of A. salmonicida. 
Solid bars indicate strains with a SFMWT/TMPWT phenotype. Diagonally striped bars indicate strains with SFMNWT/TMPWT phenotype and horizontally 
striped bars indicate those with a SFMNWT/TMPNWT phenotype. The vertical line indicates the cut-off value estimated by NRI analysis. 
statistical parameters of the distributions of the 26 strains 
isolated in Scotland and the 63 strains isolated in the other 
countries. These statistical parameters demonstrate that, on 
average, the Scottish strains (means 23.0 mm and 24.3 mm) 
were less susceptible than the others (means 30.7 mm and 
29.7 mm). Mann–Whitney analysis demonstrated that for both 
laboratories, the difference between the Scottish and non- 
Scottish data sets were significant (p b 0.001). The most 
plausible explanation of these significant differences was that 
the Scottish strain set contained some strains of reduced 
susceptibility. The high coefficients of variation recorded by 
both laboratories for the Scottish strains, however, suggest that 
not all the Scottish strains could be considered as manifesting 
reduced susceptibility. Fig. 2 separately identifies the data 
generated by Laboratory 1 from the 33 Scottish strains (solid 
bars) and from the 73 strains isolated in other countries (striped 
bars). This histogram demonstrates that, with respect to the 89 
strains that gave zones N 7 mm, some but not all of the Scottish 
strains gave zones that lay to the smaller end of the distri- 
bution. A similar analysis (not shown) of the data from Labo- 
ratory 2 gave essentially the same results. 
Taken together the NRI analysis and the analysis by 
country of origin provided strong evidence that the 89 strains 
that gave zones N 7 mm should not be treated as a diffuse but 
essentially homogeneous group. Rather these analyses suggest 
that there were at least two sub-populations within this group 
and that these sub-populations could not be identified using 
data from SFT25 discs. 
3.2. Studies with SFM100 and TMP5 discs 
In order to further investigate the susceptibility of strains 
that gave zones N 7 mm with SFT25 discs, an investigation was 
made of the zones generated by these discs and by discs 
containing 25 μg SFT25, 5 μg trimethoprim (TMP5) and 
100 μg sulfmethoxazole (SFM100). This study included 91 of 
the 106 strains used in the inter-laboratory studies with SFT25
discs. 
Figs. 3 and 4 present the distributions of zone sizes 
SFM and WT or intermediate with respect to TMP (SFMWT/ 
TMPWT). The second group contained 21 strains, 17 of which 
originated in Scotland, that were classified as NWT with 
respect to SFM but WT with respect to TMP (SFMNWT/ 
TMPWT). The third group of 17 strains were those classified as 
NWT with respect to both agents (SFMNWT/TMPNWT). No 
strains were observed to be SFMWT/TMPNWT. 
Fig. 5 presents the zone sizes recorded for the 91 strains 
using SFT25 discs, classified by their susceptibility to SFM and 
TMP. These data demonstrate that strains classified as 
SFMNWT/TMPWT generated smaller zones for SFT discs 
than those classified as fully susceptible to both agents. 
4. Discussion
4.1. Analysis of SFT25 disc data 
Waterworth (1978) reported the World Health 
Organisation recommendation that, in using disc 
diffusion methods to test susceptibility to potentiated 
sulphonamides, the susceptibilities to the two compo- 
nents should be determined independently. Current 
practice in laboratories serving aquaculture appears 
not to follow this recommendation. In a recent survey 
(Smith, 2006) 22 of 23 European laboratories reported 
testing for susceptibility to SFT by disc diffusion. Of 
these, 18 reported using SFT25 discs and four reported 
using SFT discs with 10-fold higher content. However, 
none of these laboratories reported using discs contain- 
ing SFM or TMP. Recently published standard testing 
protocols appear to follow this practice. The disc 
diffusion protocols specified by both Alderman and 
Smith (2001) and M42-A (CLSI, 2006a), which are 
functionally identical, both recommend the use of SFT25
discs and neither make any recommendation with 
respect to discs containing SFM or TMP. 
The data generated by Laboratory 2 from the 
obtained for TMP5 and SFM100 discs respectively. In each case 
the distributions were essentially bi-modal. Application of NRI application of SFM 
 
100 and TMP5 discs  demonstrated 
analysis led to an estimated cut-off value for WT strains of 
≥ 21 mm for TMP5. This allowed 73 strains to be classified as 
WT, 17 as NWT with one strain being given an intermediate 
classification. With respect to the SFM100 data the cut-off 
value for WT strains was calculated to be ≥9 mm. This limit 
led to the classification of 38 strains as NWT and 53 as WT. 
However, as there was considerable high zone end trailing in 
the SFM100 data, this limit should be treated with some 
caution. These classifications with respect to SFM can be 
compared with those produced for oxytetracycline (OTC) for 
the same strains (Smith et al., in press). Of strains classified as 
SFMNWT 98% were also classified as OTCNWT but of those 
classified as SFMWT only 19% were classified as OTCNWT. 
Using these SFM100 and TMP5 cut-off values all 91 strains 
could be classified as belonging to one of three groups. One 
group contained 53 strains classified as WT with respect to 
the existence of three, distinct phenotypic classes. One 
class was comprised of strains fully susceptible to both 
agents (SFMWT/TMPWT), the second class was com- 
prised of strains fully susceptible to neither (SFMNWT/ 
TMPNWT) and a third that was comprised of strains not 
fully susceptible to SFM but fully susceptible to TMP 
(SFMNWT/TMPWT). An important observation made in 
the inter-laboratory study was that data generated using 
SFT25 discs were unable to separate strains with these 
different susceptibilities to the individual components of 
SFT. A visual examination of the data generated from 
these discs allowed only a separation of these strains 
into two groups. One group was defined as those strains 
that gave zones of b 7 mm and the other contained all the 
other 89 strains. Although NRI analysis of the SFT discs 
data indicated that there were, in all probability, some 
strains of reduced susceptibility within this group of 89 
strains, it was not capable of generating a limit or cut-off 
value that would have allowed the identification of the 
two phenotypic classes that could be identified by the 
use of SFM100 and TMP5 discs. Fig. 5 demonstrates that 
the distributions of zone sizes generated by SFT25 discs 
for SFMNWT/TMPWT strains overlapped with those 
obtained for strains classified as SFMWT/TMPWT. Given 
this degree of overlap it must be accepted that no form of 
analysis of data generated by the use of SFT25 disc data 
could ever provide a cut-off value that would allow the 
unambiguous differentiation of these two phenotypic 
classes. 
The data generated in this work provide strong 
arguments in favour of the use of discs that contain the 
separate components of any potentiated sulphonamide 
combination. The data presented in Figs. 3 and 4 would 
suggest that NRI analysis would be capable of 
generating limit values for each component that could 
be used to detect the three phenotypic classes identified 
in this work. 
4.2. NRI cut-off values and clinical breakpoints 
Cut-off values for WT strains, calculated using NRI 
analysis, are not clinical breakpoints. These limit values 
are set using only laboratory data on susceptibility and 
can, therefore, relate only to in-vitro bacterial pheno- 
types. Clinical breakpoints, however, should relate to 
the prediction of the outcome of a therapy and can, 
therefore, be set only if consideration is also given to 
pharmacokinetic/pharmacodynamic (PK/PD) data and 
to data on clinical efficacy (Turnidge and Paterson, 
2007). With respect to the therapy of disease in aquatic 
animals we are a long way from having the PK/PD and 
clinical efficacy data that would be required to set 
clinical breakpoints. In such situations, Kahlmeter et al. 
(2003) have argued that it is legitimate to use 
epidemiological cut-off values generated from distribu- 
tions of MIC data, to estimate provisional and tentative 
breakpoints. 
It is instructive to examine the breakpoints currently in 
use in European laboratories (Smith, 2006) in the light of 
the data presented here. In this work strains that were 
SFMNWT/TMPWT gave zones in the range 15 – 26 mm 
for SFT25 discs. Of the 18 laboratories reporting 
breakpoints for SFT25 discs, 16 used limits of ≤ 14 mm 
to define resistance and one used a limit of 16 mm. Thus, 
only one laboratory, which used a breakpoint of 23 mm, 
would have regularly reported these SFMNWT/TMPWT 
strains as resistant. Possibly more importantly, three- 
quarters of these laboratories used a breakpoint of 
≤ 18 mm to define sensitivity and, therefore, presented 
with the data obtained in this work, would have classified 
and reported the majority of SFMNWT/TMPWT strains as 
fully sensitive. 
4.3. Clinical significance of the SFMNWT/TMPWT 
phenotype 
It is important to note that, at present, we do not have 
any data relating to the clinical significance of the levels of 
resistance to SFT manifest by strains that belong to the 
SFMNWT/TMPWT phenotypic class. Ringertz et al. (1997) 
have argued that, in interpreting susceptibility test data, 
emphasis should be placed on detecting resistance and 
that tentative breakpoints should, therefore, be set conser- 
vatively. There is an increasing demand that antimicrobial 
use in all fields, including aquaculture (WHO, 2006) 
should be prudent. In this context, it would be unwise to 
adopt interpretative criteria that would allow strains, 
which are not fully susceptible, to be classified as 
sensitive. In the absence of any evidence to the contrary, 
the demonstration of anything less than full susceptibility 
in a target bacterium should be treated as adequate 
grounds for issuing a recommendation that a proposed 
course of therapy should not be initiated. 
5. Conclusions
The data presented in this work demonstrates that 
when SFT25 discs are used, the M42-A protocols (CLSI, 
2006b) lack the sensitivity required to separate strains 
with different susceptibility phenotypes. They demon- 
strate, however that unambiguous separation of these 
phenotypic classes can be achieved if SFM100 and TMP5
discs are employed. This strongly argues that, in 
determining susceptibility to potentiated sulphona- 
mides, best-practice guidelines should recommend the 
use of individual discs containing the separate compo- 
nents of the potentiated mixture, rather than those 
containing the mixture itself. 
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